The Dresden-based company will produce five batches of Urteste's Panuri and Panuri Control Kits. These will be used for analytical evaluations, validation tests and a planned clinical trial. The co-operation marks an important step towards bringing innovative diagnostics into clinical application more quickly. BIOTYPE is focussing on high-quality and scalable production solutions to support primary tests in a crucial development phase. Together, the two partners aim to advance precision diagnostics and provide new impetus for the international IVD industry.
Press release "BIOTYPE" from 07/08/2025